Advances in information security, privacy, and ethics book series,
Journal Year:
2023,
Volume and Issue:
unknown, P. 120 - 142
Published: June 23, 2023
The
spread
of
the
COVID-19
pandemic
made
us
rethink
need
for
integrating
modern
scientific
algorithms
in
decision
support
as
well
medical
systems.
This
chapter
focuses
on
on-going
efforts
throughout
world
tackling
with
use
artificial
intelligence
and
machine
learning
algorithms.
also
compiles
various
internationally
providing
solution
to
this
disease.
examples
like
neural
network,
fuzzy
clustering,
vector
machines
both
disease
recognition
aid
have
been
stated.
Finally,
reiterates
developing
even
more
advanced
prediction
systems
case
future
outbreaks
due
ever
mutating
microorganisms
other
lifestyle
problems.
More
than
just
governmental
endeavors,
prudent
handling
any
emergency
health
situation
requires
awareness
self-discipline
exercised
by
inhabitants
country.
Jornal Brasileiro de Pneumologia,
Journal Year:
2025,
Volume and Issue:
unknown, P. e20240385 - e20240385
Published: Feb. 4, 2025
Objective:
To
predict
COVID-19
in
hospitalized
patients
with
SARS
a
city
southern
Brazil
by
using
machine
learning
algorithms.
Methods:
The
study
sample
consisted
of
=
18
years
age
admitted
to
the
emergency
department
and
Hospital
Escola
-
Universidade
Federal
de
Pelotas
between
March
December
2020.
Epidemiological,
clinical,
laboratory
data
were
processed
algorithms
order
identify
patterns.
Mean
AUC
values
calculated
for
each
combination
model
oversampling/undersampling
techniques
during
cross-validation.
Results:
Of
total
100
SARS,
78
had
information
RT-PCR
testing
SARS-CoV-2
infection
therefore
included
analysis.
Most
(58%)
female,
mean
was
61.4
±
15.8
years.
Regarding
models,
random
forest
slightly
higher
median
performance
when
compared
other
models
tested
adopted.
most
important
features
diagnose
leukocyte
count,
PaCO2,
troponin
levels,
duration
symptoms
days,
platelet
multimorbidity,
presence
band
forms,
urea
age,
D-dimer
an
87%.
Conclusions:
Artificial
intelligence
represent
efficient
strategy
high
clinical
suspicion,
particularly
situations
which
health
care
systems
face
intense
strain,
such
as
pandemic.
Cureus,
Journal Year:
2023,
Volume and Issue:
unknown
Published: May 1, 2023
During
the
early
phase
of
COVID-19
pandemic,
reverse
transcriptase-polymerase
chain
reaction
(RT-PCR)
testing
faced
limitations,
prompting
exploration
machine
learning
(ML)
alternatives
for
diagnosis
and
prognosis.
Providing
a
comprehensive
appraisal
such
decision
support
systems
their
use
in
management
can
aid
medical
community
making
informed
decisions
during
risk
assessment
patients,
especially
low-resource
settings.
Therefore,
objective
this
study
was
to
systematically
review
studies
that
predicted
or
severity
disease
using
ML.
Following
Preferred
Reporting
Items
Systematic
Reviews
Meta-Analysis
(PRISMA),
we
conducted
literature
search
MEDLINE
(OVID),
Scopus,
EMBASE,
IEEE
Xplore
from
January
1
June
31,
2020.
The
outcomes
were
prognostic
measures
as
death,
need
mechanical
ventilation,
admission,
acute
respiratory
distress
syndrome.
We
included
peer-reviewed
observational
studies,
clinical
trials,
research
letters,
case
series,
reports.
extracted
data
about
study's
country,
setting,
sample
size,
source,
dataset,
diagnostic
outcomes,
prediction
measures,
type
ML
model,
accuracy.
Bias
assessed
Prediction
model
Risk
Of
ASsessment
Tool
(PROBAST).
This
registered
International
Prospective
Register
(PROSPERO),
with
number
CRD42020197109.
final
records
extraction
66.
Forty-three
(64%)
used
secondary
data.
majority
Chinese
authors
(30%).
Most
(79%)
relied
on
chest
imaging
prediction,
while
remainder
various
laboratory
indicators,
including
hematological,
biochemical,
immunological
markers.
Thirteen
explored
predicting
severity,
rest
diagnosis.
Seventy
percent
articles
deep
models,
30%
traditional
algorithms.
reported
high
sensitivity,
specificity,
accuracy
models
(exceeding
90%).
overall
concern
bias
"unclear"
56%
studies.
mainly
due
concerns
selection
bias.
may
help
identify
patients
particularly
context
imaging.
Although
these
reflect
exhibit
accuracy,
novelty
biases
dataset
make
them
replacement
clinicians'
cognitive
decision-making
questionable.
Continued
is
needed
enhance
robustness
reliability
Seminars in Respiratory and Critical Care Medicine,
Journal Year:
2023,
Volume and Issue:
44(01), P. 100 - 117
Published: Jan. 16, 2023
Abstract
Coronavirus
disease
2019
(COVID-19)
pneumonia
caused
by
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
has
resulted
in
significant
mortality
pandemic
proportions.
Inflammation
response
to
the
infection
contributes
pathogenesis
of
pneumonia.
This
review
will
discuss
prior
studies
on
use
glucocorticoids
treat
infections,
rationale
for
COVID-19,
and
existing
data.
We
also
highlight
outstanding
research
questions
future
studies.
Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(5)
Published: May 1, 2023
During
COVID-19
pandemic,
artificial
neural
network
(ANN)
systems
have
been
providing
aid
for
clinical
decisions.
However,
to
achieve
optimal
results,
these
models
should
link
multiple
data
points
simple
models.
This
study
aimed
model
the
in-hospital
mortality
and
mechanical
ventilation
risk
using
a
two
step
approach
combining
variables
ANN-analyzed
lung
inflammation
data.A
set
of
4317
hospitalized
patients,
including
266
patients
requiring
ventilation,
was
analyzed.
Demographic
(including
length
hospital
stay
mortality)
chest
computed
tomography
(CT)
were
collected.
Lung
involvement
analyzed
trained
ANN.
The
combined
then
unadjusted
multivariate
Cox
proportional
hazards
models.Overall
associated
with
ANN-assigned
percentage
(hazard
ratio
[HR]:
5.72,
95%
confidence
interval
[CI]:
4.4-7.43,
p
<
0.001
>50%
tissue
affected
by
pneumonia),
age
category
(HR:
5.34,
CI:
3.32-8.59
cases
>80
years,
0.001),
procalcitonin
2.1,
1.59-2.76,
0.001,
C-reactive
protein
level
(CRP)
2.11,
1.25-3.56,
=
0.004),
glomerular
filtration
rate
(eGFR)
1.82,
1.37-2.42,
0.001)
troponin
2.14,
1.69-2.72,
0.001).
Furthermore,
is
also
ANN-based
13.2,
8.65-20.4,
involvement),
age,
1.91,
1.14-3.2,
0.14,
eGFR
1.2-2.74,
0.004)
variables,
diabetes
2.5,
1.91-3.27,
cardiovascular
cerebrovascular
disease
3.16,
2.38-4.2,
chronic
pulmonary
2.31,
1.44-3.7,
0.001).ANN-based
strongest
predictor
unfavorable
outcomes
in
represents
valuable
support
tool